Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.

Share:
More In Business
Why Students Should Learn How to Use ChatGPT
Annie Chechitelli, chief product officer at Turnitin, breaks down how students and teachers alike can learn from artificial intelligence – while still maintaining academic integrity.
Load More